Clete A. Kushida, M.D., Ph.D.
Publication Details
-
Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Clin Neuropharmacol. 2009 Nov-Dec; (6): 311-20
Assess the efficacy and tolerability of gabapentin enacarbil (GEn), a transported prodrug of gabapentin with improved gabapentin exposure, in adults with moderate-to-severe primary restless legs syndrome.
Help